Literature DB >> 19626859

[Reparative isolation and purification of flavones from Pericarpium Citri Reticulatae by high-speed counter-current chromatography].

Yinshi Sun1, Zhengbo Liu, Jianhu Wang, Ying Wang, Lixiang Zhu, Lailing Li.   

Abstract

Three flavones were prepared, isolated and purified from Pericarpium Citri Reticulatae by high-speed counter-current chromatography (HSCCC). A two-phase solvent system composed of light petroleum-ethyl acetate-methanol-water (2:4:3:3, v/v/v/v) was used. Within 6 hours, 10.1 mg of heseridin, 49.8 mg of 5,6,7,8,4'-pentamethoxyflavone and 50.6 mg of 5-hydroxy-6,7,8,3',4'-pentamethoxyflavone with their purities over 97.0% were obtained from 4.0 g of the crude extract of Pericarpium Citri Reticulatae in one-step elution under the conditions of a flow rate of 1.70 mL/min, 800 r/min and the detection wavelength of 280 nm. The obtained fractions were analyzed by high performance liquid chromatography (HPLC), and identified by mass spectrometry (MS), 1H-nuclear magnetic resonance (NMR) and 13C-NMR. The results indicate that HSCCC is a powerful technique for the purification of flavones from Citrus reticulata Blanco.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19626859

Source DB:  PubMed          Journal:  Se Pu        ISSN: 1000-8713


  2 in total

1.  A novel pentamethoxyflavone down-regulates tumor cell survival and proliferative and angiogenic gene products through inhibition of IκB kinase activation and sensitizes tumor cells to apoptosis by cytokines and chemotherapeutic agents.

Authors:  Kanokkarn Phromnoi; Simone Reuter; Bokyung Sung; Sahdeo Prasad; Ramaswamy Kannappan; Vivek R Yadav; Wisinee Chanmahasathien; Pornngarm Limtrakul; Bharat B Aggarwal
Journal:  Mol Pharmacol       Date:  2010-10-07       Impact factor: 4.436

2.  Characterization of Chemical Composition of Pericarpium Citri Reticulatae Volatile Oil by Comprehensive Two-Dimensional Gas Chromatography with High-Resolution Time-of-Flight Mass Spectrometry.

Authors:  Kunming Qin; Lijuan Zheng; Hao Cai; Gang Cao; Yajing Lou; Tulin Lu; Yachun Shu; Wei Zhou; Baochang Cai
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-28       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.